共 155 条
[1]
Hsu WL(2017)Head and neck cancer incidence trends in Taiwan, 1980–2014 Int J Head Neck Sci 1 180-189
[2]
Yu KJ(2003)An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92-98
[3]
Chiang CJ(2014)A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer Ann Oncol 25 216-225
[4]
Chen TC(2013)Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial Lancet Oncol 14 257-264
[5]
Wang CP(2001)Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 M146-M156
[6]
Adelstein DJ(2017)Functional and cognitive impairment, social environment, frailty and adverse health outcomes in older patients with head and neck cancer: A systematic review Oral Oncol 64 27-36
[7]
Li Y(2020)Patients with head and neck cancer: Are they frailer than patients with other solid malignancies? Eur J Cancer Care (Engl) 29 e13170-611
[8]
Adams GL(2020)Clinical significance of vulnerability assessment in patients with primary head and neck cancer undergoing definitive concurrent chemoradiation therapy Int J Radiat Oncol Biol Phys 108 602-2347
[9]
Hitt R(2018)Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology J Clin Oncol 36 2326-2603
[10]
Grau JJ(2014)International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer J Clin Oncol 32 2595-990